Investigation Report on China Recombinant Factor Market, 2010-2019


Posted July 1, 2015 by Rashmi

"The Report Investigation Report on China Recombinant Factor Market, 2010-2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

 
Description

Hemophilia is a hereditary bleeding disorder caused by a lack of clotting factor or Ⅸ, though not rare, which affects mostly males. Hemophilia A (clotting factor deficiency) is the most common form of the disorder. The number of the cases of hemophilia is about over 0.4 million around the world while that in China is about 0.06-0.1 million, among which 80% lack clotting factor while over half are in severe conditions.

View Full Report at: http://www.marketresearchreports.biz/analysis/289172

Injecting clotting factor might be the only effective way to treat hemophilia. Recombinant factor (Kogenate Bayer) made by Bayer was approved by FDA and EMEA in 2000 to be used in many countries. In developed countries, the drugs for the prevention and treatment of hemophilia have a huge market. Apart from Bayer Schering, Baxter and Wyeth also make recombinant factor too.

After entering China, recombinant factor develops fast with annual sales value rising from less than CNY 6 million in 2009 to CNY 93.78 million in 2014 and CAGR reaching up to 76.8% during 2009-2014. Currently, recombinant factor in the Chinese market are all imported drugs. They mainly come from the following three companies: Baxter Bioscience Manufacturing (SW), Wyeth Farma S.A. (SP) and Bayer (the US), among which Bayer (the US) has the largest market share of 57.40% by sales value in 2014.

As hemophiliacs’ ability to pay for medical treatment keeps increasing due to economic development, the market size of recombinant factor in China is expected to keep expanding.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/289172

Readers can get at least the following information from this report:

sales status of recombinant factor in China
price of recombinant factor in Chinese market
major manufacturers of recombinant factor in Chinese market
share of dosage forms of recombinant factor in China
market outlook of recombinant factor in China

The author suggests the following groups of people purchase this report:

manufacturers of blood products
investors/ research institutions interested in China blood products market
any interest in the Chinese medicine market, please contact CRI for customized survey service


Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz

Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz

Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By RASHMI SARAF
Website MarketResearchReports.biz
Business Address 90 Sate Street, Suite 700 Albany, NY 12207
90 Sate Street, Suite 700 Albany, NY 12207
Country United States
Categories Technology
Tags market , reports , research
Last Updated July 1, 2015